7 research outputs found

    Global well-posedness for the KP-I equation on the background of a non localized solution

    Full text link
    We prove that the Cauchy problem for the KP-I equation is globally well-posed for initial data which are localized perturbations (of arbitrary size) of a non-localized (i.e. not decaying in all directions) traveling wave solution (e.g. the KdV line solitary wave or the Zaitsev solitary waves which are localized in xx and yy periodic or conversely)

    Genome-wide single-nucleotide polymorphism arrays demonstrate high fidelity of multiple displacement-based whole-genome amplification

    No full text
    Whole-genome DNA amplification by multiple displacement (MD-WGA) is a promising tool to obtain sufficient DNA amounts from samples of limited quantity. Using Affymetrix' GeneChip Human Mapping 10K Arrays, we investigated the accuracy and allele amplification bias in DNA samples subjected to MD-WGA. We observed an excellent concordance (99.95%) between single-nucleotide polymorphisms (SNPs) called both in the nonamplified and the corresponding amplified DNA. This concordance was only 0.01% lower than the intra-assay reproducibility of the genotyping technique used. However, MD-WGA failed to amplify an estimated 7% of polymorphic loci. Due to the algorithm used to call genotypes, this was detected only for heterozygous loci. We achieved a 4.3-fold reduction of noncalled SNPs by combining the results from two independent MD-WGA reactions. This indicated that inter-reaction variations rather than specific chromosomal loci reduced the efficiency of MD-WGA. Consistently, we detected no regions of reduced amplification, with the exception of several SNPs located near chromosomal ends. Altogether, despite a substantial loss of polymorphic sites, MD-WGA appears to be the current method of choice to amplify genomic DNA for array-based SNP analyses. The number of nonamplified loci can be substantially reduced by amplifying each DNA sample in duplicate

    Application of genomewide SNP arrays for detection of simulated susceptibility loci

    No full text
    The prospect of SNP-based genomewide association analysis has been extensively discussed, but practical experiences remain limited. We performed an association study using a recently developed array of 11,555 SNPs distributed throughout the human genome. A total of 104 DNA samples were hybridized to these chips with an average call rate of 97% (range 85.3-98.6%). The resulting genomewide scans were applied to distinguish between carriers and noncarriers of 37 test variants, used as surrogates for monogenic disease traits. The test variants were not contained in the chip and had been determined by other methods. Without adjustment for multiple testing, the procedure detected 24% of the test variants, but the positive predictive value was low (2%). Adjustment for multiple testing eliminated most false-positive associations, but the share of true positive associations decreased to 10-12%. We also simulated fine-mapping of susceptibility loci by restricting testing to the immediate neighborhood of test variants (±5 Mb). This increased the proportion of correctly identified test variants to 22-27%. Simulation of a bigenic inheritance reduced the sensitivity to 1%. Similarly adverse effect had reduction of allelic penetrance. In summary, we demonstrate the feasibility and considerable specificity of SNP array-based association studies to detect variants underlying monogenic, highly penetrant traits. The outcome is affected by allelic frequencies of chip SNPs, by the ratio between simulated "cases" and "controls," and by the degree of linkage disequilibrium. A major improvement is expected from raising the density of the SNP array

    Improved catalyst performance of Ni/SiO2 in vegetable oil hydrogenation: Impact of Mg dopant

    No full text
    Mg-doped co-precipitated Ni/SIG precursors were studied as edible sunflower oil hydrogenation catalysts applying two types of commercial silica gels (SIG) as supports of different texture characteristics: a microporous type (SIG-A) and a mesoporous type (SIG-C). It was found that texture parameters of both the silica gels and magnesium addition allow obtaining of catalysts of various hydrogenation activities and fatty acid composition of the products. The results reveal the highest hydrogenation activity of MgNi/SIG-C catalyst because of higher amount and accessibility of metal nickel particles on the catalyst surface generated through reduction procedure. A dominant activity of MgNi/SIG-C catalyst is ascribed to appropriate mesoporosity, which controls diffusion. It was established that Mg-doped Ni/SIG-C possessed a capacity for use as an efficient edible vegetable oil hydrogenation catalyst due to high hydrogenation activity, high saturation level of linoleic acid (C18:2cis), moderate amounts of C18:1trans fatty acids, and C18:0 stearin acid formation in the partially hydrogenated sunflower oil

    Whole genome amplification in preimplantation genetic diagnosis*

    No full text
    Preimplantation genetic diagnosis (PGD) refers to a procedure for genetically analyzing embryos prior to implantation, improving the chance of conception for patients at high risk of transmitting specific inherited disorders. This method has been widely used for a large number of genetic disorders since the first successful application in the early 1990s. Polymerase chain reaction (PCR) and fluorescent in situ hybridization (FISH) are the two main methods in PGD, but there are some inevitable shortcomings limiting the scope of genetic diagnosis. Fortunately, different whole genome amplification (WGA) techniques have been developed to overcome these problems. Sufficient DNA can be amplified and multiple tasks which need abundant DNA can be performed. Moreover, WGA products can be analyzed as a template for multi-loci and multi-gene during the subsequent DNA analysis. In this review, we will focus on the currently available WGA techniques and their applications, as well as the new technical trends from WGA products

    The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects

    No full text
    corecore